Lisa M. Giles
CIK 1568850 · last filed 2025-06-12
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$45.8K
Companies
4
Total Filings
29
Lifetime Open-Market Net
$50.9K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| MIST | Director | — | $1.27 | — | $0 | 6 | 2025-06-12 |
| HCWB | Director | 35,815 | $1.28 | $45.8K | $0 | 5 | 2024-06-17 |
| GenMark Diagnostics, Inc. (GNMK) Delisted | Director | 0 | $24.04 | $0 | $35.8K | 14 | 2021-04-22 |
| Durata Therapeutics, Inc. (DRTX) Delisted | Director | 1,500 | — | — | $15.1K | 3 | 2014-01-23 |
Recent Filings · Page 3 of 3
29 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2016-08-16 | GenMark Diagnostics, Inc. (GNMK) Delisted | Buy (P) | +823 | $7.7K | EDGAR |
| 2016-05-31 | GenMark Diagnostics, Inc. (GNMK) Delisted | Grant (A) | +8,497 | $0 | EDGAR |
| 2015-11-04 | GenMark Diagnostics, Inc. (GNMK) Delisted | Buy (P) | +4,000 | $26.4K | EDGAR |
| 2015-06-01 | GenMark Diagnostics, Inc. (GNMK) Delisted | Grant (A) | +6,483 | $0 | EDGAR |
| 2015-02-23 | GenMark Diagnostics, Inc. (GNMK) Delisted | Grant (A) | +1,730 | $0 | EDGAR |
| 2014-11-19 | — | Disp (D) | −2,500 | $0 | |
| 2014-01-23 | Durata Therapeutics, Inc. (DRTX) Delisted | Buy (P) | +500 | $4.1K | EDGAR |
| 2013-12-03 | Durata Therapeutics, Inc. (DRTX) Delisted | Buy (P) | +1,000 | $10.9K | EDGAR |
| 2013-05-20 | Durata Therapeutics, Inc. (DRTX) Delisted | Grant (A) | — | $0 | EDGAR |
Showing 21–29 of 29
Prev
Page 3 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.